NEW YORK–(BUSINESS WIRE)–Perfect Corp., the leading AI and AR beauty and fashion technology provider and developer of ‘Beautiful AI’ solutions, proudly announces a major update to its Online Service for Virtual Glasses Try-On. The new feature introdu…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Healio, CEDARS/ASPENS announce mentorship program
Healio and CEDARS/ASPENS, a society of cornea, cataract and refractive surgery specialists, will launch an exclusive mentorship program at OSN New York in November.According to a press release, the partnership aims to provide a select group of young su…
Intravitreal Injection of Retinal Progenitor Cells Shows Promise in Preclinical Study for Diabetic Retinopathy
IRVINE, Calif.–(BUSINESS WIRE)–A new preclinical study titled “Intravitreal Transplantation of Retinal Progenitor Cells Improves Outcome Measures in a Rat Model of Diabetic Retinopathy” reports that retinal progenitor cells (RPCs) may provide both fu…
Mutation-Agnostic Gene Therapy May Restore Vision in RP
The MCO-010 vector uses surviving cells in the retina to produce a photosensitive protein that may help patients regain some vision despite a loss of typical photoreceptors. Medscape Medical News
Specialists share views on cryopreserved, dehydrated amniotic membranes
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.Amniotic membranes are widely used in the treatment o…